Group One Trading
CAI

Group One Trading’s Caris Life Sciences CAI Stock Holding History

Group One Trading’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
16,500
+3,000
+22% +$53.7K ﹤0.01% 3966
2026
Q1 		$241K Buy
13,500
+5,000
+59% +$109K ﹤0.01% 3963
2025
Q4 		$229K Sell
8,500
-8,300
-49% -$234K ﹤0.01% 4259
2025
Q3 		$508K Buy
+16,800
New +$536K ﹤0.01% 3689

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Group One Trading's CAI Position: Q2 2026 in Review

Group One Trading reduced its Caris Life Sciences (CAI) stake by 32% in Q2 2026, selling an estimated $103K and leaving 12,397 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #4210.

Group One Trading first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $711K in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Group One Trading held 12,397 shares of Caris Life Sciences worth $221K as of Q2 2026.
  • Group One Trading sold 5,776 Caris Life Sciences shares in Q2 2026, an estimated $103K.
  • Caris Life Sciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4210 holding.
  • Group One Trading first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Group One Trading's Caris Life Sciences position peaked at $711K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.